EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Biginelli dihydropyrimidines and their acetylated derivatives as L‐/T‐type calcium channel blockers: Synthesis, enantioseparation, and molecular modeling studies

Miyase Gözde Gündüz, Cagatay Dengiz, Katrin Denzinger, Sun Huang, J T Lee, Jordan W Nafie, Daniel W Armstrong, Gerhard Wolber, Gerald W Zamponi

Archiv der Pharmazie · 2025-03 · 358 (3)

DOI: 10.1002/ardp.202400584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 24.03.2025. Verfasst von Miyase Gözde Gündüz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Sıhhiye, Ankara, Turkey. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Calcium Channels, T-Type, Calcium Channels, L-Type, Dihydropyridines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hacettepe University Scientific Research Projects Coordination Unit (THD-2020-18712)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biginelli dihydropyrimidines (DHPMs) are considered superior over 1,4‐dihydropyridines (DHPs) in terms of both light and metabolic stabilities. Nevertheless, DHPs dominate the market as the most prescribed calcium channel blockers with strong therapeutic potential in managing cardiovascular ailments. To overcome the restrictions that complicate the formulation and postadministration of DHPs, employing bioisosteric replacement by exchanging the DHP ring with DHPM appears as a logical approach for the improved formulations of new calcium channel blockers. In this study, we obtained DHPM derivatives via Biginelli synthesis and acetylated their N ‐3 position by heating them in acetic anhydride ( GD1 – GD12 ). We also incorporated the DHPM scaffold into a condensed ring system ( GD13 and GD14 ). These DHPMs were evaluated for their ability to block both L‐ (Ca v 1.2) and T‐ (Ca v 3.2) type calcium channels. Compounds carrying acetyl moiety on the N ‐3 position of the DHPM scaffold appeared to be more effective inhibitors of both channels. Retesting GD4 enantiomers, separated using high‐performance liquid chromatography (HPLC) on a chiral stationary phase, revealed that the ( R )‐isomer predominantly contributes to the outstanding inhibitory activity of GD4 on calcium channels. Molecular modeling studies, including docking, molecular dynamics simulations, and dynophore analysis, provided insights into the binding mechanism of DHPMs to Ca v 1.2 and Ca v 3.2, for the first time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channel BlockersCalcium Channels, T-TypeCalcium Channels, L-TypeDihydropyridinesPyrimidinesAcetylationStructure-Activity RelationshipMolecular StructureStereoisomerismModels, MolecularHumans

Stichwörter der Autor:innen

Biginelli synthesischiral centermolecular dockingmolecular dynamicspatch clamp

Substanzen

Calcium Channel BlockersCalcium Channels, T-TypeCalcium Channels, L-TypeDihydropyridinesPyrimidines

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Sıhhiye, Ankara, Turkey.
  • Department of Chemistry, Middle East Technical University, Ankara, Turkey.
  • Molecular Design Group, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
  • Department of Clinical Neurosciences, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.
  • AZYP, LLC, Arlington, Texas, USA.
  • BioTools Inc., Jupiter, Florida, USA.

Förderung

  • Hacettepe University Scientific Research Projects Coordination Unit (THD-2020-18712).

Zitieren

APA

Gündüz, M. G., Dengiz, C., Denzinger, K., Huang, S., Lee, J. T., Nafie, J. W., Armstrong, D. W., Wolber, G., & Zamponi, G. W. (2025). Biginelli dihydropyrimidines and their acetylated derivatives as L‐/T‐type calcium channel blockers: Synthesis, enantioseparation, and molecular modeling studies. Archiv der Pharmazie, 358(3). https://doi.org/10.1002/ardp.202400584

Vancouver

Gündüz MG, Dengiz C, Denzinger K, Huang S, Lee JT, Nafie JW, et al. Biginelli dihydropyrimidines and their acetylated derivatives as L‐/T‐type calcium channel blockers: Synthesis, enantioseparation, and molecular modeling studies. Archiv der Pharmazie. 2025;358(3). doi:10.1002/ardp.202400584

BibTeX
@article{Gndz2025,
  author = {Gündüz, Miyase Gözde and Dengiz, Cagatay and Denzinger, Katrin and Huang, Sun and Lee, J T and Nafie, Jordan W and Armstrong, Daniel W and Wolber, Gerhard and Zamponi, Gerald W},
  title = {Biginelli dihydropyrimidines and their acetylated derivatives as L‐/T‐type calcium channel blockers: Synthesis, enantioseparation, and molecular modeling studies},
  journal = {Archiv der Pharmazie},
  year = {2025},
  volume = {358},
  number = {3},
  doi = {10.1002/ardp.202400584}
}
Kostenlos starten →